Tocilizumab, a biologic disease-modifying antirheumatic drug targeting interleukin 6, reduces disease activity more ...
After the first 6 months of disease-modifying antirheumatic drugs (DMARDs) use in patients with rheumatoid arthritis (RA), most very abnormal results newly seen in long-term routine laboratory ...
Rheumatoid arthritis is a chronic autoimmune disorder causing inflammation of synovial joints, leading to pain, stiffness, ...
Hilary Capell: rheumatologist whose research was grounded in the “complex realities of patient care”
When Hilary Capell became a consultant rheumatologist in 1978, at the age of just 29, there were very few options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback